Papers

Research literature with structured metadata.

Trials

Registered studies by status, phase, and compound.

Topics

Indications and themes psychedelics are researched for.

Compounds

Evidence across molecules with rich data.

Countries

Regulation, access, and research activity by region.

Stakeholders

Organizations shaping the space across research, policy, and funding.

People

Investigators, clinicians, and authors with mapped output.

Courses

Training programs and certifications across modalities.

Events

Conferences, workshops, and convenings by date and focus.

Results

Compare outcome data across trials and publications.

Research Snapshot

One-page overview of trials, participants, papers, and research networks.

Clinical Guidelines

Trial-anchored manuals and protocol guidance with competency mapping.

Research recaps

Monthly evidence summaries with key takeaways.

Map of research

Landscape view of trials, compounds, and outcomes.

Newsletter

Weekly or daily updates on trials, publications, analysis, and more.

Research Groups

Worldwide map of psychedelic research centres by region.

Road to Access

Science, regulation, and economics on the path to patient access.

Research Network

Interactive co-authorship map of psychedelic researchers.

Top papers

Find needles in the haystack of psychedelic research per topic.

AskBeta
Pricing

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners
  • Clinical Guidelines

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.

Home/Research/Mescaline/Veterans

Mescaline for Veterans

1 paper and 0 clinical trials exploring mescaline as a treatment for veterans.

CompoundPhenethylamine

Mescaline

A naturally occurring phenethylamine psychedelic found in certain cacti, investigated for its role in religious practice and psychiatric research.

Full Mescaline profile
IndicationApproximately 1 in 10 veterans are diagnosed with PTSD and around 30% of veterans experience depression.

Veterans

Psychedelic treatments are emerging as promising therapeutic options for veterans dealing with mental health conditions, particularly post-traumatic stress disorder (PTSD) and treatment-resistant depression. Recent clinical trials highlight the efficacy of compounds such as MDMA and psilocybin in alleviating symptoms and improving overall quality of life.

Full Veterans profile

Academic Research

1 paper
Open Accessmeta

MDA, MDMA and other mescaline-like substances in the US military’s search for a truth drug (1940s to 1960s)

This review (2017) summarizes the history of the US military's attempt to operationalize psychotropic drugs, first scopolamine, and mescaline then later on MDMA and other derivatives, as a truth serum. These attempts were largely futile because scopolamine induced a delirium-like state of mind which raised doubt over the validity of the extracted information, whereas psychedelic substances produced excessive hallucinations, thought disturbance, and confusion, which hindered the interrogation process.

Published
August 29, 2017
Journal
Drug Testing and Analysis
Authors
Passie, T., Benzenhöfer, U.

Clinical Trials

0 trials

No clinical trials have been tagged with both Mescaline and Veterans yet.

Trials are continuously being added as new studies are registered.

Explore further

Search all Mescaline papers Search all Veterans trials Full Mescaline profile Full Veterans profile